184 related articles for article (PubMed ID: 20212482)
1. Patenting biotech beyond the central dogma.
Wu G
Nat Biotechnol; 2010 Mar; 28(3):230-3. PubMed ID: 20212482
[No Abstract] [Full Text] [Related]
2. Biotechnology patenting policy in the European Union--as exemplified by the development in Germany.
Schrell A; Bauser H; Brunner H
Adv Biochem Eng Biotechnol; 2007; 107():13-39. PubMed ID: 17522818
[TBL] [Abstract][Full Text] [Related]
3. Biotech patents and the inequitable conduct doctrine.
Michael A
Nat Biotechnol; 2006 Oct; 24(10):1219-21. PubMed ID: 17033655
[No Abstract] [Full Text] [Related]
4. The patenting of novel biotech products.
Webber PM
IDrugs; 2007 Jul; 10(7):459-62. PubMed ID: 17642015
[TBL] [Abstract][Full Text] [Related]
5. Biotech patents: looking backward while moving forward.
Eisenberg RS
Nat Biotechnol; 2006 Mar; 24(3):317-9. PubMed ID: 16525404
[No Abstract] [Full Text] [Related]
6. US Supreme Court decision could compromise biotech patents.
Robertson D
Nat Biotechnol; 2001 May; 19(5):394. PubMed ID: 11328981
[No Abstract] [Full Text] [Related]
7. Biotechnology. Lawsuit challenges legal basis for patenting human genes.
Marshall E
Science; 2009 May; 324(5930):1000-1. PubMed ID: 19460975
[No Abstract] [Full Text] [Related]
8. European Commission rethinks biotech patents.
Mitchell P
Nat Biotechnol; 2002 Dec; 20(12):1175-6. PubMed ID: 12454654
[No Abstract] [Full Text] [Related]
9. Of mice and men: patenting the oncomouse.
Knowles LP
Hastings Cent Rep; 2003; 33(2):6-7. PubMed ID: 12760110
[No Abstract] [Full Text] [Related]
10. Obviousness, hindsight and perspective: the impact of KSR v. Teleflex on biotech and pharmaceutical patents.
Teitelbaum R; Cohen M
Nat Biotechnol; 2007 Oct; 25(10):1105-6. PubMed ID: 17921990
[No Abstract] [Full Text] [Related]
11. Patentable subject matter, TRIPS and the European Biotechnology Directive: Australia and patenting human genes.
Palombi L
Univ N S W Law J; 2003; 26(3):782-92. PubMed ID: 16617532
[No Abstract] [Full Text] [Related]
12. The CREATE Act: increasing costs associated with the biotech industry?
Mills AE; Chen DT; Gillon JJ; Tereskerz PM
Nat Biotechnol; 2006 Jul; 24(7):785-6. PubMed ID: 16841059
[TBL] [Abstract][Full Text] [Related]
13. Biotech patents-business as usual?
Lawrence S
Nat Biotechnol; 2008 Dec; 26(12):1326. PubMed ID: 19060861
[No Abstract] [Full Text] [Related]
14. A benchside guide to patents and patenting.
Johnson E
Nat Biotechnol; 1996 Mar; 14(3):288-91. PubMed ID: 9630888
[No Abstract] [Full Text] [Related]
15. Patenting DNA: just when you thought it was safe.
Chahine KG
Nat Biotechnol; 1997 Jun; 15(6):586-8. PubMed ID: 9181584
[No Abstract] [Full Text] [Related]
16. Supreme Court boosts licensees in biotech patent battles.
Waltz E
Nat Biotechnol; 2007 Mar; 25(3):264-5. PubMed ID: 17344866
[No Abstract] [Full Text] [Related]
17. Intellectual property. Decision on NFkappaB patent could have broad implications for biotech.
Garber K
Science; 2006 May; 312(5775):827. PubMed ID: 16690824
[No Abstract] [Full Text] [Related]
18. Proposed changes to patent code loom over biotech industry.
Coombs A
Nat Biotechnol; 2007 Dec; 25(12):1333-4. PubMed ID: 18066010
[No Abstract] [Full Text] [Related]
19. US court bolsters biotech patent protection.
Harrison C
Nat Biotechnol; 2011 Aug; 29(8):672-3. PubMed ID: 21822224
[No Abstract] [Full Text] [Related]
20. Patent reform acts ugly.
Nat Biotechnol; 2007 Nov; 25(11):1187. PubMed ID: 17989652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
